Nunzia Pharmaceutical EBITDA vs. Total Asset
| NUNZ Stock | USD 0 0.00 0.00% |
For Nunzia Pharmaceutical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Nunzia Pharmaceutical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Nunzia Pharmaceutical utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Nunzia Pharmaceutical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Nunzia Pharmaceutical over time as well as its relative position and ranking within its peers.
Nunzia |
Nunzia Pharmaceutical Total Asset vs. EBITDA Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Nunzia Pharmaceutical's current stock value. Our valuation model uses many indicators to compare Nunzia Pharmaceutical value to that of its competitors to determine the firm's financial worth. Nunzia Pharmaceutical is regarded second in ebitda category among its peers. It is considered to be number one stock in total asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Nunzia Pharmaceutical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Nunzia Pharmaceutical's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Nunzia Total Asset vs. EBITDA
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Nunzia Pharmaceutical |
| = | (9.02 M) |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Nunzia Pharmaceutical |
| = | 5.13 K |
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
Nunzia Total Asset Comparison
Nunzia Pharmaceutical is currently under evaluation in total asset category among its peers.
Nunzia Pharmaceutical Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Nunzia Pharmaceutical, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Nunzia Pharmaceutical will eventually generate negative long term returns. The profitability progress is the general direction of Nunzia Pharmaceutical's change in net profit over the period of time. It can combine multiple indicators of Nunzia Pharmaceutical, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Nunzia Pharmaceutical Company operates as a pharmaceutical and nutraceutical company. Nunzia Pharmaceutical Company was incorporated in 1986 and is based in Long Beach, California. Nunzia Pharmaceutical is traded on OTC Exchange in the United States.
Nunzia Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Nunzia Pharmaceutical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Nunzia Pharmaceutical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Nunzia Pharmaceutical's important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in Nunzia Pharmaceutical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run ETFs Now
ETFsFind actively traded Exchange Traded Funds (ETF) from around the world |
| All Next | Launch Module |
Use Investing Themes to Complement your Nunzia Pharmaceutical position
In addition to having Nunzia Pharmaceutical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Drugs Thematic Idea Now
Drugs
Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. The Drugs theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Drugs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Nunzia Pink Sheet Analysis
When running Nunzia Pharmaceutical's price analysis, check to measure Nunzia Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nunzia Pharmaceutical is operating at the current time. Most of Nunzia Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Nunzia Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nunzia Pharmaceutical's price. Additionally, you may evaluate how the addition of Nunzia Pharmaceutical to your portfolios can decrease your overall portfolio volatility.